Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment-Reference-Cited by-同舟云学术

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment

Published:2016-04-15 Issue:5 Volume:71 Page:530-537
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Pozniak Anton,Arribas Jose R.,Gathe Joseph,Gupta Samir K.,Post Frank A.,Bloch Mark,Avihingsanon Anchalee,Crofoot Gordon,Benson Paul,Lichtenstein Kenneth,Ramgopal Moti,Chetchotisakd Ploenchan,Custodio Joseph M.,Abram Michael E.,Wei Xuelian,Cheng Andrew,McCallister Scott,SenGupta Devi,Fordyce Marshall W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference22 articles.

1. The kidney in HIV infection: beyond HIV-associated nephropathy.;Wyatt;Top Antivir Med,2012

2. . Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons.;Choi;Circulation,2010

3. . Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients.;Ibrahim;Am J Kidney Dis,2012

4. . Highly active antiretroviral therapy and the epidemic of HIV end-stage renal disease.;Schwartz;J Am Soc Nephrol,2005

5. . Chronic kidney disease in HIV infection: an urban epidemic.;Wyatt;AIDS,2007

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study;The Lancet Gastroenterology & Hepatology;2024-08

2. Bone Tissue Changes in Individuals Living with HIV/AIDS: The Importance of a Hierarchical Approach in Investigating Bone Fragility;Journal of Personalized Medicine;2024-07-26

3. Renal safety of tenofovir alafenamide-based antiretroviral therapy in people with HIV: A mini-review;BioScience Trends;2024-04-30

4. Bone Disease in HIV: Need for Early Diagnosis and Prevention;Life;2024-04-17

5. Bone turnover change after randomised switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV;AIDS;2023-12-07